Drawing for CMC NAVIGATOR

USPTO serial 79456682

CMC NAVIGATOR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
Law office

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with CMC NAVIGATOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Business consultancy and professional business consultancy in the field of biopharmaceuticals and protein therapeutics; strategic business planning and process optimisation for the development and marketing of biopharmaceutical goods; business consultancy and professional business consultancy in the field of chemistry, manufacture and controls (CMC) for biopharmaceutical goods.ACTIVE
040Manufacture of therapeutic proteins for clinical trials; industrial production in laboratories of proteins, enzymes and other biopharmaceutical materials.ACTIVE
042Science and technology services in relation to the following goods: biopharmaceuticals and protein therapeutics; research and development of protein-based medicines; cell line development; analysis and laboratory services for protein characterisation, formulation and stability testing; design, development and scientific and technical optimisation and restructuring of protein production processes; custom development of protein therapeutics; process development, formulation development and technical planning of the scaling of protein-based goods; technology transfer services, namely technical consultancy, planning and support in the implementation of biopharmaceutical manufacturing processes; quality control, analytical testing and protein characterization.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 23, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Aug 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance